THE GP-130 FAMILY CYTOKINES IL-6, LIF AND OSM BUT NOT IL-11 CAN REVERSE THE ANTIPROLIFERATIVE EFFECT OF DEXAMETHASONE ON HUMAN MYELOMA CELLS

被引:42
作者
JUGEMORINEAU, N [1 ]
FRANCOIS, S [1 ]
PUTHIER, D [1 ]
GODARD, A [1 ]
BATAILLE, R [1 ]
AMIOT, M [1 ]
机构
[1] INST BIOL,ONCOGENESE IMMUNOHEMATOL LAB,INSEAD,U211,F-44035 NANTES 01,FRANCE
关键词
MYELOMA CELL; DEXAMETHASONE; IL-6; LDF; OSM;
D O I
10.1111/j.1365-2141.1995.tb05605.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to understand the mechanisms supporting steroid escape in patients with multiple myeloma (MM), three IL-6 autocrine human myeloma cell lines, LP1, OPM2 and L363, have been treated with dexamethasone in the presence or absence of cytokines belonging to the gp 130 family: IL-6, LIF, OSM and IL-11, With pharmacological doses of dexamethasone, a dramatic growth arrest was observed in all the cell lines. IL-6 completely reversed this inhibition. Of note, this IL-6 induced reversion was still seen with very low amounts of IL-6 (12 pg/ml), Finally, whereas LIF and OSM had clear growth-promoting effects on OPM2 only, both cytokines (but not IL-11) reversed the dexamethasone-induced growth arrest in all the cell lines. Therefore the high levels of IL-6 (ng/ml) observed in the MM intermediate milieu and the putative presence of LIF and OSM can easily counteract the effects of dexamethasone in vivo.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 12 条
  • [1] ALEXANIAN R, 1992, BLOOD, V80, P887
  • [2] SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS
    BATAILLE, R
    JOURDAN, M
    ZHANG, XG
    KLEIN, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) : 2008 - 2011
  • [3] DISTELHORST CW, 1984, BLOOD, V63, P105
  • [4] HARDIN J, 1994, BLOOD, V84, P3063
  • [5] ISHIKAWA H, 1990, BLOOD, V75, P715
  • [6] AUTOCRINE GENERATION AND REQUIREMENT OF BSF-2/IL-6 FOR HUMAN MULTIPLE MYELOMAS
    KAWANO, M
    HIRANO, T
    MATSUDA, T
    TAGA, T
    HORII, Y
    IWATO, K
    ASAOKU, H
    TANG, B
    TANABE, O
    TANAKA, H
    KURAMOTO, A
    KISHIMOTO, T
    [J]. NATURE, 1988, 332 (6159) : 83 - 85
  • [7] KLEIN B, 1991, BLOOD, V78, P1198
  • [8] ONCOSTATIN-M, LEUKEMIA INHIBITORY FACTOR, AND INTERLEUKIN-6 INDUCE THE PROLIFERATION OF HUMAN PLASMACYTOMA CELLS VIA THE COMMON SIGNAL TRANSDUCER, GP130
    NISHIMOTO, N
    OGATA, A
    SHIMA, Y
    TANI, Y
    OGAWA, H
    NAKAGAWA, M
    SUGIYAMA, H
    YOSHIZAKI, K
    KISHIMOTO, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1343 - 1347
  • [9] LACK OF A ROLE OF INTERLEUKIN-11 IN THE GROWTH OF MULTIPLE-MYELOMA
    PAUL, SR
    BARUT, BA
    BENNETT, F
    COCHRAN, MA
    ANDERSON, KC
    [J]. LEUKEMIA RESEARCH, 1992, 16 (03) : 247 - 252
  • [10] EXPRESSION OF CD28 AND CD40 IN HUMAN MYELOMA CELLS - A COMPARATIVE-STUDY WITH NORMAL PLASMA-CELLS
    PELLATDECEUNYNCK, C
    BATAILLE, R
    ROBILLARD, N
    HAROUSSEAU, JL
    RAPP, MJ
    JUGEMORINEAU, N
    WIJDENES, J
    AMIOT, M
    [J]. BLOOD, 1994, 84 (08) : 2597 - 2603